Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort.

Michael K SullivanBhautesh Dinesh JaniJennifer Susan LeesClaire E WelshAlex McConnachieBethany StanleyPaul WelshBarbara I NichollDonald M LyallJuan Jesús CarreroDorothea NitschNaveed SattarFrances S MairPatrick B Mark

Published in: Clinical kidney journal (2021)

Multimorbidity, and in particular cardiometabolic multimorbidity, is a risk factor for MAKE. Future research should study groups of patients who are at high risk of progressive kidney disease based on the number and type of LTCs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
multiple sclerosis
current status
cross sectional
adverse drug
drug induced